Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gelofusine vs Ringerfundin in Hip Replacement Surgery
NCT02461329Unknown
- Start
- May 2015
- Primary completion
- Sep 2016
- Modality
- Recombinant Proteins and Enzymes, Drug Delivery Systems
01
Overview
Randomised, double-blind trial of gelatin in hypovolemia and postoperative hemorrhage. Primary endpoint: Change of coagulation status and platelet function at 2 hours. Status: unknown.
02
Drugs
gelatin
03
Conditions
hypovolemiapostoperative hemorrhage
Beyond the preview
Go deeper on NCT02461329.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02461329.